13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 97 holding rows worth $213,616,325.
- Accession
- 0001440771-26-000014
- Filer
- CIK 1440771
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 97 entries on the cover page, a total value of $213,616,325 stated on the cover page (in dollars after the unit check, H1), rows summing to $213,616,325 with VALUE read as dollars as filed, 13F file number 028-17175. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,349,627 | $12,795,575 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,590,162 | $11,035,724 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 4,990,238 | $9,623,729 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 660,000 | $9,603,000 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 120,654 | $8,422,856 | dollars as filed | |
| AZITRA INC | 05479L302 | COM NEW | 81,797,553 | $7,981,143 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 650,000 | $7,950,000 | dollars as filed | call |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 1,345,921 | $6,433,502 | dollars as filed | |
| ELOXX PHARMACEUTICALS INC | 29014R301 | COM NEW | 447,160 | $6,206,581 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 740,000 | $6,193,800 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 1,389,622 | $6,072,648 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 40,000 | $5,600,000 | dollars as filed | call |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 200,000 | $5,500,000 | dollars as filed | call |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 345,179 | $4,860,120 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 68,001 | $4,709,606 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 50,000 | $4,375,000 | dollars as filed | call |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 100,000 | $4,103,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 425,000 | $3,986,500 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 40,000 | $3,800,000 | dollars as filed | call |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 491,624 | $3,723,291 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 258,701 | $3,709,772 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 557,284 | $3,444,015 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 50,000 | $3,250,000 | dollars as filed | call |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 456,439 | $3,190,807 | dollars as filed | |
| CURIS INC | 231269309 | COM | 14,312,187 | $3,150,280 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 420,000 | $3,150,000 | dollars as filed | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 50,000 | $3,125,000 | dollars as filed | call |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 917,100 | $2,852,181 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 551,692 | $2,670,190 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 2,468,595 | $2,379,231 | dollars as filed | |
| IN8BIO INC | 45674E208 | COM NEW | 1,624,562 | $2,290,633 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 225,994 | $2,165,023 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 245,518 | $2,121,276 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 280,000 | $2,100,000 | dollars as filed | call |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 765,546 | $2,041,567 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,662,427 | $1,996,820 | dollars as filed | |
| ADIAL PHARMACEUTICALS INC | 00688A304 | COM NEW | 727,563 | $1,583,177 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 28,795 | $1,554,930 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,000,000 | $1,500,000 | dollars as filed | call |
| SI BONE INC | 825704109 | COM | 100,000 | $1,500,000 | dollars as filed | call |
| OKYO PHARMA LTD | G6724L116 | SHS NEW | 862,996 | $1,294,494 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 2,128,597 | $1,262,930 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 500,000 | $1,250,000 | dollars as filed | call |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 2,201,468 | $1,134,637 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 14,469 | $1,072,732 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 815,436 | $1,060,067 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 224,989 | $1,050,699 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 150,000 | $1,050,000 | dollars as filed | call |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 100,000 | $1,000,000 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 50,000 | $973,500 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 330,530 | $965,796 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 751,606 | $924,475 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 85,010 | $922,358 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 364,254 | $866,925 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 25,000 | $834,750 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 102,000,000 | $794,013 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 161,583 | $783,678 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 205,000 | $768,750 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 250,000 | $750,000 | dollars as filed | call |
| NERVGEN PHARMA CORP | 64082X203 | COM | 571,678 | $740,220 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 40,000 | $735,600 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 40,000 | $720,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 536,086 | $718,355 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 7,500 | $713,775 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 130,684 | $595,919 | dollars as filed | |
| SINTX TECHNOLOGIES INC | 829392703 | COM NEW | 627,615 | $558,432 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 96,172 | $539,044 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 60,000 | $498,600 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 20,000 | $490,200 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 100,718 | $413,951 | dollars as filed | |
| QT IMAGING HLDGS INC | 746962307 | COM | 100,000 | $407,000 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 154,595 | $386,488 | dollars as filed | |
| MILESTONE PHARMACEUTICALS IN | 59935P209 | COM NEW | 666,666 | $348,565 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 104,550 | $290,649 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 43,491 | $287,476 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 73,271 | $285,757 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 24,257 | $278,956 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 48,680 | $276,502 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 230,538 | $262,813 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 109,662 | $247,836 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 88,417 | $241,454 | dollars as filed | |
| PRECISION OPTICS CORP INC MA | 740294400 | COM NEW | 46,390 | $236,589 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 33,432 | $231,349 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 218,038 | $226,760 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 1,345,237 | $210,176 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 490,787 | $209,468 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 231,299 | $180,506 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 40,000 | $128,418 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 30,122 | $122,597 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 352,001 | $107,429 | dollars as filed | |
| PROCESSA PHARMACEUTICALS INC | 74275C403 | COM SHS | 55,000 | $105,600 | dollars as filed | |
| BIOATLA INC | 09077B203 | COM NEW | 16,432 | $68,028 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 31,387 | $67,168 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 294,550 | $62,125 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 21,300 | $57,297 | dollars as filed | |
| EVAXION AS | 29970R303 | SPONSORED ADS | 17,562 | $54,442 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 137,174 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001440771-26-000014 | this filing | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001440771-26-000016 | base | 2026-08-17 | acceptance time not in the bulk data set |